Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis.

Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis.

Respiratory syncytial virus (RSV) is the most common cause of early childhood lower respiratory tract infection (LRTI) in low- and middle-income countries (LMICs). Maternal vaccines, birth-dose extended half-life monoclonal antibodies (mAbs), and pediatric vaccines are under development for preventi...

Full description

Bibliographic Details
Main Authors: Rachel S Laufer, Ranju Baral, Andrea G Buchwald, James D Campbell, Flanon Coulibaly, Fatoumata Diallo, Moussa Doumbia, Amanda J Driscoll, Alison P Galvani, Adama M Keita, Kathleen M Neuzil, Samba Sow, Clint Pecenka, Justin R Ortiz, Meagan C Fitzpatrick
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLOS Global Public Health
Online Access:https://doi.org/10.1371/journal.pgph.0001432

Internet

https://doi.org/10.1371/journal.pgph.0001432

Similar Items